Invitae Corporation (NVTA)
Upgrades & Downgrades
Latest NVTA news
Penny Stocks To Buy Now? 4 Biotech Stocks To Watch Before July 2022
24 June 2022
Biotech penny stocks to watch right now. The post Penny Stocks To Buy Now?
Invitae: Coming Out Of The Cash Burn
22 June 2022
Invitae, a next-gen healthcare/biotech company, has seen its stock getting hammered due to strong worries about a looming bankruptcy due to reckless cash burn. However, in the last few quarters, the c...
Why Invitae Stock Plummeted by 15% Today
3 June 2022
Investors are taking a new, bearish analyst view on the company to heart.
3 Stocks Wall Street Thinks Could Triple Your Money or Better
31 May 2022
Find out why the pros think these stocks could gain 200% or better.
Invitae to Present at Upcoming Investor Conferences
27 May 2022
SAN FRANCISCO , May 27, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following investor co...
3 Biotech Stocks With a Cash Pile Higher Than Their Valuations
21 May 2022
Our roundtable found three biotechs with a nice cash cushion.
Why Invitae Stock Is Tumbling Today
4 May 2022
The medical genetics company reported disappointing Q1 results.
Invitae Corporation (NVTA) CEO Sean George on Q1 2022 Results - Earnings Call Transcript
3 May 2022
Invitae Corporation (NYSE:NVTA ) Q1 2022 Results Conference Call May 3, 2022 4:30 PM ET Company Participants Jack Finks - IR Sean George - CEO Roxi Wen - CFO Conference Call Participants Daniel Brenna...
Invitae: Cathie Wood's Big Loss Can Be Your Big Gain
29 April 2022
Invitae is one of the worst-performing stocks in Cathie Wood's Genomic Revolution ETF, down over 90% from the highs of $56.60 set in December 2020. The stock has become so cheap it now trades at under...